Literature DB >> 15582138

Predominance of type 1 (Th1) cytokine production in the liver of patients with HCV-associated mixed cryoglobulinemia vasculitis.

David Saadoun1, Olivier Boyer, Hélène Trébeden-Nègre, Nicolas Limal, Véronique Bon-Durand, Marita Andreu, David Klatzmann, Jean Charles Piette, Patrice Cacoub.   

Abstract

BACKGROUND/AIMS: Patients with hepatitis C virus (HCV) mixed cryoglobulinemia (MC) vasculitis have a higher mortality rate and more frequent incidence of cirrhosis than their cryoglobulin-negative counterparts. To compare the cytokine profile of liver-infiltrating T cells in HCV-infected patients with or without MC vasculitis.
METHODS: Hepatic biopsy specimens were obtained from HCV infected patients with and without MC vasculitis. Using intracellular staining and flow cytometry, we assessed the ability of freshly isolated liver T cells from these biopsies to produce IFN-gamma, TNF-alpha, IL-2, IL-4, and IL-10 in response to stimulation with PMA and ionomycin.
RESULTS: HCV-MC vasculitis patients compared to HCV-MC negative controls have an enhanced hepatic T cells production of Th1-type cytokines [i.e. TNF-alpha(30.3 +/- 13% vs. 15.5 +/- 5%, P = 0.01), IL-2 (20.2 +/- 9% vs. 10 +/- 4%, P = 0.01) and IFN-gamma (22.2 +/- 11% vs. 9.4 +/- 4%, P = 0.008)], whereas IL-10, a representative Th2-type cytokine, was significantly lower (7.2 +/- 4% vs. 17 +/- 7%, P = 0.01).
CONCLUSIONS: T cell from the liver of HCV-MC vasculitis patients display a significantly augmented liver Th1 profile compared to MC-negative controls. This enhanced production of type-1 cytokines may account for a more severe course of liver disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15582138     DOI: 10.1016/j.jhep.2004.08.011

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  7 in total

1.  Expression of biomarkers of interferon type I in patients suffering from chronic diseases.

Authors:  C Scagnolari; F Bellomi; S Trombetti; M Casato; M Carlesimo; F Bagnato; V Lavolpe; R Bruno; E Millefiorini; L Antonelli; E Girardi; O Turriziani; G Antonelli
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

2.  High circulating N-terminal pro-brain natriuretic peptide and tumor necrosis factor-alpha in mixed cryoglobulinemia.

Authors:  Alessandro Antonelli; Clodoveo Ferri; Silvia-Martina Ferrari; Fabio Galetta; Ferdinando Franzoni; Gino Santoro; Salvatore De Marco; Emiliano Ghiri; Poupak Fallahi
Journal:  World J Gastroenterol       Date:  2009-10-28       Impact factor: 5.742

3.  High interleukin-6 and tumor necrosis factor-alpha serum levels in hepatitis C infection associated or not with mixed cryoglobulinemia.

Authors:  Alessandro Antonelli; Clodoveo Ferri; Silvia Martina Ferrari; Emiliano Ghiri; Santino Marchi; Michele Colaci; Fabrizio Bruschi; Poupak Fallahi
Journal:  Clin Rheumatol       Date:  2009-06-20       Impact factor: 2.980

Review 4.  Advances in HCV and Cryoglobulinemic Vasculitis in the Era of DAAs: Are We at the End of the Road?

Authors:  Chalermrat Bunchorntavakul; Robert Mitrani; K Rajender Reddy
Journal:  J Clin Exp Hepatol       Date:  2017-12-07

Review 5.  Cytokines and HCV-related disorders.

Authors:  Poupak Fallahi; Clodoveo Ferri; Silvia Martina Ferrari; Alda Corrado; Domenico Sansonno; Alessandro Antonelli
Journal:  Clin Dev Immunol       Date:  2012-05-07

6.  Hepatitis C virus cryoglobulinemia and non-hodgkin lymphoma.

Authors:  Zohreh Jadali
Journal:  Hepat Mon       Date:  2012-02-29       Impact factor: 0.660

Review 7.  The role of virus-induced regulatory T cells in immunopathology.

Authors:  Shelly J Robertson; Kim J Hasenkrug
Journal:  Springer Semin Immunopathol       Date:  2006-07-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.